174 related articles for article (PubMed ID: 31264797)
1. Lower prepulse inhibition in clinical high-risk groups but not in familial risk groups for psychosis compared with healthy controls.
Togay B; Çıkrıkçılı U; Bayraktaroglu Z; Uslu A; Noyan H; Üçok A
Early Interv Psychiatry; 2020 Apr; 14(2):196-202. PubMed ID: 31264797
[TBL] [Abstract][Full Text] [Related]
2. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia.
Üçok A; Direk N; Koyuncu A; Keskin-Ergen Y; Yüksel Ç; Güler J; Karadayı G; Akturan E; Devrim-Üçok M
Schizophr Res; 2013 Dec; 151(1-3):265-9. PubMed ID: 24262680
[TBL] [Abstract][Full Text] [Related]
3. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
De Koning MB; Bloemen OJ; Van Duin ED; Booij J; Abel KM; De Haan L; Linszen DH; Van Amelsvoort TA
J Psychopharmacol; 2014 Jun; 28(6):553-60. PubMed ID: 24526133
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
5. Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis.
Bo Q; Mao Z; Tian Q; Yang N; Li X; Dong F; Zhou F; Li L; Wang C
Schizophr Bull; 2021 Jan; 47(1):128-137. PubMed ID: 32743658
[TBL] [Abstract][Full Text] [Related]
6. Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study.
Ziermans T; Schothorst P; Magnée M; van Engeland H; Kemner C
J Psychiatry Neurosci; 2011 Mar; 36(2):127-34. PubMed ID: 21266126
[TBL] [Abstract][Full Text] [Related]
7. Do young adolescents with first-episode psychosis or ADHD show sensorimotor gating deficits?
Rydkjaer J; Jepsen JRM; Pagsberg AK; Fagerlund B; Glenthoej BY; Oranje B
Psychol Med; 2020 Mar; 50(4):607-615. PubMed ID: 30873927
[TBL] [Abstract][Full Text] [Related]
8. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
[TBL] [Abstract][Full Text] [Related]
9. Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension.
Ivleva EI; Moates AF; Hamm JP; Bernstein IH; O'Neill HB; Cole D; Clementz BA; Thaker GK; Tamminga CA
Schizophr Bull; 2014 May; 40(3):642-52. PubMed ID: 23599252
[TBL] [Abstract][Full Text] [Related]
10. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
11. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
12. Visual P3 abnormalities in patients with first-episode schizophrenia, unaffected siblings of schizophrenia patients and individuals at ultra-high risk for psychosis.
Devrim-Üçok M; Keskin-Ergen HY; Üçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 122():110678. PubMed ID: 36427549
[TBL] [Abstract][Full Text] [Related]
13. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
[TBL] [Abstract][Full Text] [Related]
15. Failure to deactivate medial prefrontal cortex in people at high risk for psychosis.
Falkenberg I; Chaddock C; Murray RM; McDonald C; Modinos G; Bramon E; Walshe M; Broome M; McGuire P; Allen P
Eur Psychiatry; 2015 Jul; 30(5):633-40. PubMed ID: 25841662
[TBL] [Abstract][Full Text] [Related]
16. Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis.
Ouyang L; Ma X; Yuan L; Fan L; Liao A; Li D; Yang Z; Zhang Z; Liu W; Chen X; Li Z; He Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111035. PubMed ID: 38795823
[TBL] [Abstract][Full Text] [Related]
17. Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence.
Ziermans TB; Schothorst PF; Sprong M; Magnée MJ; van Engeland H; Kemner C
Schizophr Res; 2012 Jan; 134(1):10-5. PubMed ID: 22085828
[TBL] [Abstract][Full Text] [Related]
18. Neurological soft signs and prepulse inhibition of the startle reflex in psychosis: A pilot study.
Ira E; Bonetto C; Zanoni M; Bottacini A; Mazzoncini R; Martini L; Garozzo A; Lasalvia A; Tansella M; Ruggeri M; Tosato S
Int J Psychiatry Clin Pract; 2015; 19(4):276-84. PubMed ID: 25666859
[TBL] [Abstract][Full Text] [Related]
19. Antisaccade task performance in patients at ultra high risk for developing psychosis.
Nieman D; Becker H; van de Fliert R; Plat N; Bour L; Koelman H; Klaassen M; Dingemans P; Niessen M; Linszen D
Schizophr Res; 2007 Sep; 95(1-3):54-60. PubMed ID: 17656071
[TBL] [Abstract][Full Text] [Related]
20. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
